Auriga Laboratories Obtains Rights To Market And Sell A New Product Indicated For The

[forumAdmin]

Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company, announced today the signing of a license agreement with Outlook Pharmaceuticals, Inc., pursuant to which Auriga will have the exclusive rights to market and sell a new product indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the United States.

External site More Info here... (http://www.medicalnewstoday.com/articles/90761.php)
Please return here to comment...............